ATAI Life Sciences
German life sciences company focused on psychedelic therapies for mental health conditions.
7
Funding Rounds
$482.1m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Fl***** Br*** | - | - | linkedin twitter |
| Ch******* An******** |
|
- | linkedin twitter instagram |
| Sr****** Ra* | - | - | |
| La** Ch******* Wi*** | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Fl***** Br*** | - | - | linkedin twitter |
| Name | Phone | Social networks | |
|---|---|---|---|
| Fl***** Br*** | - | - | linkedin twitter |
Funding
Funding series
Funding Series Analysis
The company ATAI Life Sciences has raised a total of $482.1m in funding over 7 rounds.
Key Insights:
- ATAI Life Sciences Series D round, March 3, 2021: $157m
- Atai Life Sciences March 2021 Series D Funding Round: $160m
- ATAI Life Sciences Series C round, November 24, 2020: $93m
- Atai Life Sciences Funding Round 2019: $43m
- ATAI Life Sciences Series A round, October 3, 2018: $25.5m
- ATAI Life Sciences Seed round, June 2018: $3.6m
ATAI Life Sciences Series D round, March 3, 2021
$157m
Atai Life Sciences March 2021 Series D Funding Round
$160m
ATAI Life Sciences Series C round, November 24, 2020
$93m
Atai Life Sciences Funding Round 2019
$43m
ATAI Life Sciences Series A round, October 3, 2018
$25.5m
ATAI Life Sciences Seed round, June 2018
$3.6m
Industries
ATAI Life Sciences is active in the following industries:
Subsidiaries
ATAI Life Sciences operates through the following subsidiaries:
